Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-11-01

FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydralazine hydrochloride (Teva Pharmaceuticals USA, Inc.) under ANDA 089097, updating an already approved generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

SUPPL AP for HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)